Skip to main content

Advertisement

SpringerLink
Log in

Prognostic value of tumor deposits for long-term oncologic outcomes in patients with stage III colorectal cancer: a systematic review and meta-analysis

  • Original Article
  • Published:
International Journal of Colorectal Disease Aims and scope Submit manuscript

Abstract

Purpose

The presence of tumor deposits (TDs) in colorectal cancer is associated with a poor prognosis. In patients with the concomitant presence of both TDs and lymph nodes (LNs), there is no staging option except for the number of positive LNs alone. Therefore, to determine the prognostic value of TDs in patients with stage III colorectal cancer, meta-analyses of survival outcomes of patients with TDs were performed comparing different subgroups based on the lymph node status.

Methods

PubMed, EMBASE, and the Cochrane Library were searched. Data were pooled, and overall effect size was calculated using random-effect models. Outcome measures were 5-year overall survival (OS) and 5-year disease-free survival (DFS).

Results

We included in the analysis 18 nonrandomized studies and 1 prospective study that examined 90,455 patients. N1c patients (TD + LN-) had worse 5-year DFS than TDs-negative stage III patients (TD-LN +) with a RR of 1.30 (95% CI 1.06–1.61, I2 = 47%). In subgroup analysis, N1c patients had worse 5-year DFS (RR = 1.60, 95% CI = 1.25–2.05, I2 = 40%) compared with TDs-negative N1 patients (TD-N1) whereas N1c patients had better 5-year OS (RR = 0.72, 95% CI = 0.62–0.83, I2 = 0%) and 5-year DFS (RR = 0.75, 95% CI = 0.57–0.99, I2 = 0%) compared with TDs-negative N2 patients (TD-N2).

Conclusions

These results may suggest that current nodal staging for colorectal cancer needs modification. The presence of TDs may have more adverse oncologic outcomes than TDs-negative N1 patients. More studies are warranted to further verify these results.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424

    Article  PubMed  Google Scholar 

  2. Lo DS, Pollett A, Siu LL, Gallinger S, Burkes RL (2008) Prognostic significance of mesenteric tumor nodules in patients with stage III colorectal cancer. Cancer 112:50–54

    Article  PubMed  Google Scholar 

  3. Nagtegaal ID, Knijn N, Hugen N, Marshall HC, Sugihara K, Tot T et al (2017) Tumor Deposits in Colorectal Cancer: Improving the Value of Modern Staging-A Systematic Review and Meta-Analysis. J Clin Oncol 35:1119–1127

    Article  PubMed  Google Scholar 

  4. Gabriel WBDC, Bussey HJR (1935) Lymphatic spread in cancer of the rectum. Br J Surg 23:395–413

    Article  Google Scholar 

  5. Edge SB, Bryd DR, Compton CC, Fritz AG, Greene FL, Trotti A (2010) AJCC Cancer Staging Manual, 7th edn. Springer, New York

    Google Scholar 

  6. Amin MB, Edge SB (2017) AJCC cancer staging manual. Springer, New York

    Book  Google Scholar 

  7. Nagayoshi K, Ueki T, Nishioka Y, Manabe T, Mizuuchi Y, Hirahashi M et al (2014) Tumor deposit is a poor prognostic indicator for patients who have stage II and III colorectal cancer with fewer than 4 lymph node metastases but not for those with 4 or more. Dis Colon Rectum 57:467–474. https://doi.org/10.1097/dcr.0000000000000059

    Article  PubMed  Google Scholar 

  8. Qi QH, Wang T, Mao Y, Hua D (2016) Prognostic significance of tumor deposits in patients with stage III colon cancer. Zhonghua Zhong Liu Za Zhi 38:784–789. https://doi.org/10.3760/cma.j.issn.0253-3766.2016.10.015

    Article  CAS  PubMed  Google Scholar 

  9. Bouquot M, Creavin B, Goasguen N, Chafai N, Tiret E, André T et al (2018) Prognostic value and characteristics of N1c colorectal cancer. Colorectal Dis 20:248–255. https://doi.org/10.1111/codi.14289

    Article  Google Scholar 

  10. Landau MA, Zhu B, Akwuole FN, Pai RK (2019) Histopathological Predictors of Recurrence in Stage III Colon Cancer: Reappraisal of Tumor Deposits and Tumor Budding Using AJCC8 Criteria. Int J Surg Pathol 27:147–158. https://doi.org/10.1177/1066896918787275

    Article  CAS  PubMed  Google Scholar 

  11. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151:264–269. https://doi.org/10.7326/0003-4819-151-4-200908180-00135

    Article  Google Scholar 

  12. Higgins JP, Green S (2011) Cochrane handbook for systematic reviews of interventions, version 5.1.0 vol. 5. Chichester: John Wiley & Sons

  13. Wells GA SB, O’Connell D, Peterson J, Welch V, Losos M, Tugwell P (2021) The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Available at http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed 1 Mar 2021

  14. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557–560. https://doi.org/10.1136/bmj.327.7414.557

    Article  PubMed  PubMed Central  Google Scholar 

  15. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188. https://doi.org/10.1016/0197-2456(86)90046-2

    Article  CAS  PubMed  Google Scholar 

  16. Thabane L, Akhtar-Danesh N (2008) Guidelines for reporting descriptive statistics in health research. Nurse Res 15:72–81. https://doi.org/10.7748/nr2008.01.15.2.72.c6331

    Article  PubMed  Google Scholar 

  17. Patsopoulos NA, Evangelou E, Ioannidis JP (2008) Sensitivity of between-study heterogeneity in meta-analysis: proposed metrics and empirical evaluation. Int J Epidemiol 37:1148–1157. https://doi.org/10.1093/ije/dyn065

    Article  PubMed  PubMed Central  Google Scholar 

  18. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634. https://doi.org/10.1136/bmj.315.7109.629

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Sutton AJ, Duval SJ, Tweedie RL, Abrams KR, Jones DR (2000) Empirical assessment of effect of publication bias on meta-analyses. BMJ 320:1574–1577. https://doi.org/10.1136/bmj.320.7249.1574

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Tateishi S, Arima S, Futami K, Kawahara K, Tachikawa D, Naritomi K et al (2005) A clinicopathological investigation of “tumor nodules” in colorectal cancer. Surg Today 35:377–384. https://doi.org/10.1007/s00595-004-2950-y

    Article  PubMed  Google Scholar 

  21. Tong LL, Gao P, Wang ZN, Song YX, Xu YY, Sun Z et al (2012) Is the seventh edition of the UICC/AJCC TNM staging system reasonable for patients with tumor deposits in colorectal cancer? Ann Surg 255:208–213. https://doi.org/10.1097/SLA.0b013e31821ad8a2

  22. Yabata E, Udagawa M, Okamoto H (2014) Effect of tumor deposits on overall survival in colorectal cancer patients with regional lymph node metastases. J Rural Med 9:20–26. https://doi.org/10.2185/jrm.2880

    Article  PubMed  PubMed Central  Google Scholar 

  23. Li X, An B, Zhao Q, Qi J, Wang W, Zhang D et al (2018) Impact of tumor deposits on the prognosis and chemotherapy efficacy in stage III colorectal cancer patients with different lymph node status: A retrospective cohort study in China. Int J Surg 56:188–194. https://doi.org/10.1016/j.ijsu.2018.06.029

    Article  PubMed  Google Scholar 

  24. Wang Y, Zhang J, Zhou M, Yang L, Wan J, Shen L et al (2019) Poor prognostic and staging value of tumor deposit in locally advanced rectal cancer with neoadjuvant chemoradiotherapy. Cancer Med 8:1508–1520. https://doi.org/10.1002/cam4.2034

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Pei JP, Zhang CD, Liang Y, Zhang C, Wu KZ, Li YZ et al (2020) A Modified Pathological N Stage Including Status of Tumor Deposits in Colorectal Cancer With Nodal Metastasis. Front Oncol 10:548692. https://doi.org/10.3389/fonc.2020.548692

    Article  PubMed  PubMed Central  Google Scholar 

  26. Wong-Chong N, Motl J, Hwang G, Nassif GJ Jr, Albert MR, Monson JRT et al (2018) Impact of Tumor Deposits on Oncologic Outcomes in Stage III Colon Cancer. Dis Colon Rectum 61:1043–1052. https://doi.org/10.1097/dcr.0000000000001152

    Article  PubMed  Google Scholar 

  27. Belt EJ, van Stijn MF, Bril H, de Lange-de Klerk ES, Meijer GA, Meijer S et al (2010) Lymph node negative colorectal cancers with isolated tumor deposits should be classified and treated as stage III. Ann Surg Oncol 17:3203–3211. https://doi.org/10.1245/s10434-010-1152-7

    Article  PubMed  PubMed Central  Google Scholar 

  28. Shimada Y, Takii Y (2010) Clinical impact of mesorectal extranodal cancer tissue in rectal cancer: Detailed pathological assessment using whole-mount sections. Dis Colon Rectum 53:771–778. https://doi.org/10.1007/DCR.0b013e3181cf7fd8

    Article  PubMed  Google Scholar 

  29. Ueno H, Hashiguchi Y, Shimazaki H, Shinto E, Kajiwara Y, Nakanishi K et al (2014) Peritumoral deposits as an adverse prognostic indicator of colorectal cancer. Am J Surg 207:70–77. https://doi.org/10.1016/j.amjsurg.2013.04.009

    Article  PubMed  Google Scholar 

  30. Basnet S, Lou QF, Liu N, Rana R, Shah A, Khadka M et al (2018) Tumor deposit is an independent prognostic indicator in patients who underwent radical resection for colorectal cancer. J Cancer 9:3979–3985. https://doi.org/10.7150/jca.27475

    Article  PubMed  PubMed Central  Google Scholar 

  31. Benoit O, Svrcek M, Creavin B, Bouquot M, Challine A, Chafai N et al (2020) Prognostic value of tumor deposits in rectal cancer: A monocentric series of 505 patients. J Surg Oncol 122:1481–1489. https://doi.org/10.1002/jso.26165

    Article  PubMed  Google Scholar 

  32. Delattre JF, Cohen R, Henriques J, Falcoz A, Emile JF, Fratte S et al (2020) Prognostic Value of Tumor Deposits for Disease-Free Survival in Patients With Stage III Colon Cancer: A Post Hoc Analysis of the IDEA France Phase III Trial (PRODIGE-GERCOR). J Clin Oncol 38:1702–1710. https://doi.org/10.1200/jco.19.01960

    Article  PubMed  Google Scholar 

  33. Yu L, Xu T, Zhang L, Zhu Y, Fang H, Zhang H (2020) Tumor Deposits Should Not Be Ignored in the AJCC TNM Staging System for ypN(+) Stage Rectal Cancer with Neoadjuvant Chemoradiotherapy. J Gastrointest Surg 24:2298–2301. https://doi.org/10.1007/s11605-020-04675-7

    Article  PubMed  Google Scholar 

  34. Zhang J, Fan WN, Liu XL (2020) Correlation between tumor deposit and prognosis in patients with stage III colorectal cancer. J Xi’an Jiaotong Univ 41:97–101 and 119. https://doi.org/10.7652/jdyxb202001018

  35. Li J, Yang S, Hu J, Liu H, Du F, Yin J et al (2016) Tumor deposits counted as positive lymph nodes in TNM staging for advanced colorectal cancer: a retrospective multicenter study. Oncotarget 7:18269–18279

    Article  PubMed  PubMed Central  Google Scholar 

  36. Song YX, Gao P, Wang Zn, Liang Jw, Sun Z, Wang MX et al (2012) Can the tumor deposits be counted as metastatic lymph nodes in the UICC TNM staging system for colorectal cancer? PLoS One 7:e34087

  37. Frankel WL, Jin M (2015) Serosal surfaces, mucin pools, and deposits, oh my: challenges in staging colorectal carcinoma. Mod Pathol 28:S95-108

    Article  PubMed  Google Scholar 

  38. Fan XJ, Fau WX, Yang -, Z-L, Yang Zl Fau - Fu X-H, Fu Xh Fau - Huang Y, Huang Y Fau - Chen D-K, Chen Dk Fau - Song S-X et al (2013) Snail promotes lymph node metastasis and Twist enhances tumor deposit formation through epithelial-mesenchymal transition in colorectal cancer. Hum Pathol 44:173–180

    Article  CAS  PubMed  Google Scholar 

  39. Mirkin KA, Kulaylat AS, Hollenbeak CS, Messaris E (2018) Prognostic Significance of Tumor Deposits in Stage III Colon Cancer. Ann Surg Oncol 25:3179–3184. https://doi.org/10.1245/s10434-018-6661-9

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

None.

Author information

Authors and Affiliations

  1. Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk National University Hospital, San 2-20 Geumam-dong, Deokjin-gu, Jeonju, Jeonbuk, 561-180, South Korea

    Jae Young Moon, Min Ro Lee & Gi Won Ha

Authors
  1. Jae Young Moon
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Min Ro Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gi Won Ha
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gi Won Ha.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Moon, J.Y., Lee, M.R. & Ha, G.W. Prognostic value of tumor deposits for long-term oncologic outcomes in patients with stage III colorectal cancer: a systematic review and meta-analysis. Int J Colorectal Dis 37, 141–151 (2022). https://doi.org/10.1007/s00384-021-04036-z

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00384-021-04036-z

Keywords

Search

Navigation